<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><data_sharing_plan>IPD Sharing (as of September 2018): No</data_sharing_plan><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Radiotherapy</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Radiotherapy</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2243543</full_dataset_link><location>China</location><study_start_month>1</study_start_month><keyword>Maintenance treatment</keyword><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer</name><description>This study is a randomized phase II trial of maintenance chemotherapy versus consolidative radiotherapy plus maintenance chemotherapy for patients with unresectable metastatic colorectal cancer (MCRC).</description><dates><creation>2019-01-15</creation></dates><accession>2243543</accession><cross_references><ClinicalTrials___gov>NCT03142282</ClinicalTrials___gov></cross_references></HashMap>